Registration defined

Here we present several commercially available robots used for surgical tool positioning, which we classify on the basis of the used registration method. The registration defines the geometrical transformation between the preoperative plan and the intraoperative environment in which the task is defined. 

FIFRA Sections 3 and 4 pertain to registration and reregistration of pesticides, with clearly defined data requirements as outlined in Tide 40 of the US. Code of federal Regulations (51). About 120 different studies are Hsted, most of which are to be done on technical-grade active ingredients (TGAIs). 

The requirements for product approval are defined in the reference manuals. You may not need to prepare product approval submissions for all the parts you supply. The applicability of product approval procedures is affected by several factors so definitive solutions cannot be offered. The fundamental requirement is that if you supply product to the automotive customers you need a product approval procedure in place to gain ISO/TS 16949 registration. If you have been supplying parts for some time without product approval then you should confirm with your customer that you may continue to do so. 

When EPA became aware almost five years ago that N-nitroso contaminants occurred in a number of pesticide products, the Agency immediately acted on the authority of Section 3 of FIFRA to place a moratorium on new registrations of pesticides suspected to contain N-nitroso contaminants at detectable levels (this term is defined and explained later in the text). As has been discussed in other papers of the Symposium, many N-nitroso compounds are animal carcinogens and, consequently, suspected human carcinogens. 

Reproducibility in the context of Directive 96/46/EC is defined as a validation of the repeatability of recovery, from representative matrices at representative levels, by at least one laboratory, which is independent of the laboratory which initially validated the study. This independent laboratory may be within the same company, but may not be involved in the development of the method. This concept of independent laboratory validation (ILV) substitutes the conduct of interlaboratory trials (e.g., according to ISO 5725) because the resources are not available taking into consideration the high number of a.i., matrix types and concentration levels which must be validated in the registration procedure. 

The registrant may submit residue data on any number of processed fractions. Table 1 of the 860 Series just defines what the EPA is required. A registrant may be wise to take a proactive approach and collect residue data on additional processed commodities for use in dietary exposure assessments. 

This article defines the criteria and processes for computer validation. Computer validation applies to all systems, including electronic capture systems in both the laboratory (scientific instrumentation) and field settings. Any system producing electronic records and documents, which regulators in the evaluation of product registration applications will use, needs to be validated. 

Coordination is needed on a global scale to fulfill registrants role and commitment to make EDS a reality in NAFTA and OECD countries. To accomplish all this, well-defined plans need to be developed through an industry-government partnership and followed up with specific actions. 

For this, the manufacturer and the importer have to register the chemicals they are placing on the European market. The registration is mandatory for all chemicals that are sold in a volume of more than 1 Mg/a. With the registration the manufacturer and the importer have to provide a special registration dossier. This dossier should cover all necessary information to do the safety check. To be precise, the structure of the dossier has to follow well-defined requirements, which will not be explained in this article. More information is offered here [10, 11]. 

Bachem produces biochemical and pharmaceutical compounds, and offers complementary services on a proprietary technology platform. Although, oriented to the Health Sector, it supports synthetic methods from customers for defined target structures up to the registration of new compounds. Consequently, R D activities are also a strong part of Bachem business that encourages collaborations with technology partners to produce new active substances. 

The presence of one carbon atom in a molecule of carbon dioxide results in registration of the molecular ion peak of m/z 44 and of the A + 1 isotopic peak of m/z 45. The intensity of the latter is 1.1 % of that of M+. It appears due to the presence of 13C02 molecules. An increase in the number of carbon atoms in a molecule leads to an increase of the intensity of the M + 1 ion peak to 1.1 n% of M+, where n is the number of carbon atoms in the molecule. To calculate the number of carbon atoms in a molecule using a mass spectrum one should divide the intensity of the M + 1 peak as a percentage of M by 1.1. The result defines the maximum possible number of carbon atoms. One should remember that calculations may be more complicated if an [M — H]+ ion peak is present. 

The Most Intense Peaks. It is not so easy to extract valuable information dealing with the most intense peaks in mass spectra. In contrast to other physicochemical methods (IR, NMR, UV), registration of an ion peak of an integer m/z value does not provide an unequivocal identification of its structure or even composition. Even accurate mass measurements (high resolution mass spectrometry) defining the elemental composition of an ion does not establish its structure, as it could be formed directly from the M+, with minimal distortion of the authentic structure, or as a result of numerous rearrangement processes. 

Risk Assessment Technical Guidance Document (a. 16), which will presumably apply to registration under REACH. The adequacy of each test can be defined by two basic elements ... 

Stationary source. USEPA defined source to include the entire facility. Sources are still required to submit one RMP and one registration as part of that RMP for all processes at the source with more than a threshold quantity of a regulated substance. 

How Will Conducting a Clinical Trial in a Pharmacogenetically Defined Subset of Patients Influence the Collection of Adequate Safety and Efficacy Data Prior to Registration ... 

---